Abstract
Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy affecting women of reproductive age, manifested with a variety of clinical signs, none of which is pathognomonic. The association of insulin resistance and reproductive abnormalities with clinical hyper-androgenism in a woman was first demonstrated by Achard and Thiers in the “diabetes of bearded woman.” The link of PCOS with insulin resistance was subsequently established by clinical studies characterizing the profound insulin resistance in obese and lean PCOS patients. Insulin resistance, hyperinsulinemia, and beta-cell dysfunction are very common in PCOS, but are not required for the diagnosis. The numerous in vivo and in vitro data supporting the central role of insulin resistance in the pathogenesis of PCOS found a broad clinical application in the management of the syndrome, where the regulation of cycle abnormalities and the facilitation of pregnancy in obese PCOS patients was assisted by co-administration of agents such as the well-known insulin sensitizers. The documentation of the presence of insulin resistance contributed substantially to unravel several metabolic components present in the syndrome. Today our knowledge about PCOS appers to have broader health implications and to have profoundly altered our view of the gravity of this condition.
Similar content being viewed by others
References
Diamanti-Kandarakis, E., Koulie, C. R., Bergiele, A. T., et al. (1999) J. Clin. Endocrinol. Metab 84, 4006–4011.
Asuncion, M., Calvo, R. M., San Millan, J. L., Sancho, J., Avila, S., and Escobar-Morreale, H. F. (2000). J. Clin. Endocrinol. Metab. 85, 2434–2438.
Azziz, R., Woods, K. S., Reyna, R., et al. (2004). J. Clin. Endocrinol. Metab. 8, 2745–2749.
Zawdaki, J. K. and Dunaif, A. (1992). In Polycystic ovary syndrome. Dunaif, A., Givens, J. R., Haseltine, F., and Merriam, G. R. (eds.), Blackwell Scientific: Boston, pp. 377–384.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (2004). Fertil. Steril 81, 19–25.
Rotterdam ESHRE-ASRM Sponsored PCOS consensus work-shop group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum. Reprod. 19, 41–47.
Cussons, A. J., Stuckey, B. G., Walsh, J. P., Burke, V., and Norman, R. J. (2005). Clin. Endocrinol. (Oxf.) 62(3), 289–295.
Legro, R. S., Kunselmann, A. R., Dodson, W. C., and Dunaif, A. (1999). J. Clin. Endocrinol. Metab 84, 165–169.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., and Imperial, J. (1999). Diabetes Care 22, 141–146.
Gambineri, A., Pelusi, C., Manicardi, E., et al. (2004). Diabetes 53(9), 2353–2358.
Legro, R. S., Kunselman, A. R., and Dunaif, A. (2001). Am. J. Med. 111(8), 607–613.
Diamanti-Kandarakis, E., Spina, G., Kouli, C., and Migdalis, I. (2001). J. Clin. Endocrinol. Metab. 86, 4666–4673.
Kahn, C. R. (1985). Ann. Rev. Med. 36, 429–451.
Mantzoros, C. S. and Flier, J. S. (1995). Adv. Endocrinol. Metab. 6, 193–232.
World Health Organization (WHO) Expert Committee on Diabetes Mellitus Second Report. (1980). Technical Report Series 646. World Health Organization, Geneva, Switzerland.
Reaven, G. M. (1988). Diabetes 37, 1595–1607.
Balkau, B., Charles, M. A., Drivsholm, T., et al. (2002). Diabetes Metab. 28, 364–376.
Rosen, E. D. and Spiegelman, B. M. (1999). Curr. Opin. Endocrin. Diab. 6, 170–176.
White, M. F. and Kahn, C. R. (1994). J. Biol. Chem. 269, 1–4.
White, M. F. (1998). Mol. Cell Biochem. 182, 3–11.
Velazquez, M. E., Bellabarba, G. A., Mendoza, S., and Sanchez, L. (2000). Fertil. Steril. 74(6), 1159–1163.
Goodarzi, M. O., Erickson, S., Port, S. C., Jennrich, R. I., and Korenman, S. G. (2003). Metabolism 52(6), 713–719.
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., and Guzick, D. S. (2004). J. Clin. Endocrinol. Metab. 89, 6061–6067.
Diamanti-Kandarakis, E., Piperi, C., Kalofoutis, A., and Creatsas, G. (2005). Clin. Endocrinol. (Oxf.) 62(1), 37–43.
Diamanti-Kandarakis, E., Palioniko, G., Alexandraki, K., Bergiele, A., Koutsouba, T., and Bartzis, M. (2004). Eur. J. Endocrinol. 150, 795–800.
Dunaif, A., Segal, K. R., Futterweit, W., and Dobrjansky, A. (1989). Diabetes 38, 1165–1174.
Morales, A. J., Laughlin, G. A., Butzow, T., Maheshwari, H., Baumann, G., and Yen, S. S. (1996). J. Clin. Endocrinol. Metab. 81, 2854–2864.
Ovesen, P., Moller, J., Ingerslev, H. J., et al. (1993). J. Clin. Endocrinol. Metab. 77, 1636–1640.
Diamanti-Kandarakis, E., Kouli, C., Alexandraki, K., and Spina, G. (2004). J. Clin. Endocrinol. Metab. 89(3), 1273–1276.
Dunaif, A. and Finegood, D. T. (1996). J. Clin Endocrinol. Metab. 81, 942–947.
Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., and Polonsky, K. S. (1995). J. Clin. Invest. 96 520–527.
O'Meara, M., Blackman, J. D., Ehrmann, D. A., et al. (1993). J. Clin. Endocrinol Metab. 76, 1241–1247.
Arslanian, S. A., Lewy, V. D., and Danadian, K. (2001). J. Clin. Endocrinol. Metab. 86, 66–71.
Dunaif, A. (1997). Endocr. Rev. 18, 774–800.
Colilla, S., Cox, N. J., and Ehrmann, D. A. (2001). J. Clin. Endocrinol. Metab. 86, 2027–2031.
Holte, J., Bergh, T., Berne, C., and Lithell, H. (1994). Clin. Endocrinol. (Oxf.) 41(4), 463–471.
Holte, J., Bergh, T., Berne, C., Wide, L., and Lithell, H. (1995). J. Clin. Endocrinol. Metab. 80, 2586–2593.
Sozen, I. and Arici, A. (2000). Obstet. Gynecol. Surv. 55(5), 321–328.
Book, C. B. and Dunaif, A. (1999). J. Clin. Endocrinol. Metab. 84(9), 3110–3116.
Dunaif, A., Xia, J., Book, C.-B., Schenker, E., and Tang, Z. (1995). J. Clin. Invest. 96, 801–810.
Dunaif, A., Wu, X., Lee, A., and Diamanti-Kandarakis, E. (2001). Am. J. Physiol. Endocrinol. Metab. 281(2), E392–399.
Rosenbaum, D., Haber, R. S., and Dunaif, A. (1993). Am. J. Physiol. 264(2 Pt 1), E197–202.
Seow, K. M., Juan, C. C., Wu, L. Y., et al. (2004). Hum. Reprod. 19, 48–53.
Panidis, D., Koliakos, G., Kourtis, A., Farmakiotis, D., Mousiech, T., and Rousso, D. (2004). Fertil. Steril. 81(2), 361–366.
Panidis, D., Kourtis, A., Farmakiotis, D., Mouslech, T., Rousso, D., and Koliakos, G. (2003). Hum. Reprod. 18, 1790–1796.
Orio, F., Palomba, S., Cascella, T., et al. (2003). J. Clin. Endocrinol. Metab. 88, 2619–2623.
Burghen, G. A., Givens, J. R., and Kitabchi, A. E. (1980). J. Clin. Endocrinol. Metab. 50, 113–116.
Barbieri, R. L., Smith, S., and Ryan, K. J. (1988). Fertil. Steril. 50(2), 197–212.
Sam, S. and Dunaif, A. (2003). Trends Endocrinol. Metab. 14(8), 365–370.
Nestler, J. E., Jakubowicz, D. J., de Vargas, A. F., Brik, C., Quintero, N. and Medina, F. (1998). J. Clin. Endocrinol. Metab. 83, 2001–2005.
Gilling-Smith, C., Willis, D. S., Beard, R. W., and Franks, S. (1994). J. Clin. Endocrinol. Metab. 79, 1158–1165.
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., and Giudice, L. C. (1999). Endocr. Rev. 20, 535–582.
Lindstedt, G., Lundberg, P. A., Lapidus, L., Lundgren, H., Bengtsson, C., and Bjorntorp, P. (1991). Diabetes 40, 123–128.
Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., and Pasquali, R. (2002). Int. J. Obesity 26, 883–896.
Nagamani, M., Van Dinh, T., and Kelver, M. E. (1986). Am. J. Obst. Gynec. 154, 384–389.
Geffner, M. E., Kaplan, S. A., Bersch, N., Golde, D. W., Landaw, E. M., and Chang, R. J. (1986). Fertil. Steril. 45, 327–333.
Diamanti-Kandarakis, E., Mitrakou, A., Hennes, M. M., et al. (1995). Metabolism, 44, 525–531.
Elkind-Hirsch, K. E., Valdes, C. T., and Malinak, L. R. (1993). Fertil. Steril. 60, 634–641.
Moghetti, P., Tosi, F., Castello, R., et al. (1996). J. Clin. Endocrinol. Metab. 81, 952–960.
Conn, J. J., Jacobs, H. S., and Conway, G. S. (2000). Clin. Endocr. 52, 81–86.
Dunaif, A., Graf, M., Mandeli, J., Laumas, V., and Dobrjansky, A. (1987). J. Clin. Endocrinol. Metab., 65, 499–507.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Diamanti-Kandarakis, E. Insulin resistance in PCOS. Endocr 30, 13–17 (2006). https://doi.org/10.1385/ENDO:30:1:13
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:30:1:13